| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | ||
|---|---|---|---|---|---|---|
Revenues | ||||||
25,000 | 0 | 0 | 0 | 0 | ||
Operating expenses: | ||||||
Research and development | ||||||
157,610 | 82,887 | 39,514 | 20,163 | 12,475 | ||
Selling, general, and administrative | ||||||
68,116 | 21,212 | 11,421 | 5,675 | 5,135 | ||
Total operating expenses | ||||||
225,726 | 104,099 | 50,935 | 25,838 | 17,610 | ||
Loss from operations | ||||||
-200,726 | -104,099 | -50,935 | -25,838 | -17,610 | ||
Other income (expense): | ||||||
Interest and other income, net | ||||||
8,537 | 4,329 | 746 | 4 | 3 | ||
Interest expense | ||||||
67 | 84 | 95 | 106 | 2,209 | ||
Total other income (expense), net | ||||||
8,470 | 4,245 | 651 | -102 | -2,206 | ||
Net loss | ||||||
-192,300 | -99,900 | -50,300 | -25,940 | -19,816 | ||
Net loss per share—basic and diluted (in dollars per share) | ||||||
-4.48 | -2.82 | -2.99 | -2.23 | -4.67 | ||
Weighted average common shares outstanding—basic and diluted (in shares) | ||||||
42,869 | 35,390 | 16,792 | 11,626 | 4,245 | ||
Comprehensive loss: | ||||||
Net loss | ||||||
-192,300 | -99,900 | -50,300 | - | - | ||
Other comprehensive income (loss): | ||||||
Unrealized gains (losses) on marketable securities | ||||||
111 | 0 | 0 | - | - | ||
Total other comprehensive income (loss) | ||||||
111 | 0 | 0 | - | - | ||
Total comprehensive loss | ||||||
-192,145 | -99,854 | -50,284 | - | - | ||